-
1 Comment
Yantai Dongcheng Pharmaceutical Group Co.,Ltd is currently in a long term uptrend where the price is trading 5.8% above its 200 day moving average.
From a valuation standpoint, the stock is 12.1% more expensive than other stocks from the Basic Materials sector with a price to sales ratio of 4.5.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd's total revenue rose by 9.7% to $931M since the same quarter in the previous year.
Its net income has increased by 18.1% to $119M since the same quarter in the previous year.
Finally, its free cash flow grew by 261.1% to $263M since the same quarter in the previous year.
Based on the above factors, Yantai Dongcheng Pharmaceutical Group Co.,Ltd gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100001DP5 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Dividend Yield | 1.2% |
|---|---|
| Market Cap | 12B |
| PE Ratio | 87.94 |
| Target Price | 15.5 |
| Beta | 0.32 |
Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas. It offers heparin, chondroitin sulphate sodium and calcium, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C. The company also provides nadroparin calcium, hydrocortisone sodium succinate, chorionic gonadotrophin, and menotropins for injection, as well as ambroxol hydrochloride dispersible tablets, jinjunling capsule, metformin hydrochloride and glibenclamide tablets, clemastine fumarate tablets, and wind dispelling itch relieving granule. In addition, it offers Technetium [99Tc] Methylene Diphosphonate Injection; Technetium [99mTc] Tc labeled tracers; 2-[18F]FDG that helps to detect the activity of tumor cells; sodium iodide [131I] oral solution; iodine [125I] seed use to treat internal radiation of various malignant tumors; [14C]Urea capsule; and jiabaolin glucosamine chondroitin sulfate capsule. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002675.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
